From these studies, we propose that DNMT1 downregulation leading to TMZ resistance in glioma cells results in the demethylation of the miR-20a promoter, thereby causing the promotion of miR-20a expression and the development of chemoresistance. This evidence concerns the gene DNMT1 and central nervous system cancer.